Stay updated with breaking news from Patrick Riley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Government to channel investments toward procuring qualified platforms that embrace multiple customers and stakeholders, finds Frost & Sullivan SANTA CLARA,
Adopting Cloud Platforms will Improve Federal Healthcare Agency Interoperability and Customer Experience, from Frost & Sullivan.
/PRNewswire/ -- Payment integrity solutions are evolving in terms of technology, strategy, and services for higher claim accuracy. As administrative and...
Former Bristol Myers Squibb compatriots are reuniting at Flagship Pioneering. Natural killer cell biotech Acepodia has enlisted AbbVie oncology exec Thorsten Graef as its chief medical officer. And Centessa has called upon a former AstraZeneca heavyweight as its new CMO.
Published: May 13, 2021 By Alex Keown Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by mutations in both copies of the RPE65 gene. Prior to Spark, Reape was senior vice president of clinic...